Investor Relations

INVESTORS & MEDIA

Investor Relations

Events
Jun 14 11:40 AM EDT Jun 14, 2022 | 11:40 AM EDT
Goldman Sachs 43rd Annual Global Healthcare Conference
Jun 10 10:30 AM EDT Jun 10, 2022 | 10:30 AM EDT
2022 Annual Meeting of Shareholders
May 10 4:20 PM EDT May 10, 2022 | 4:20 PM EDT
BofA Securities Healthcare Conference
We are a leading science and technology company that delivers life-transforming medicines for serious diseases.

Founded by physician-scientists more than 30 years ago, our science-driven approach has resulted in nine FDA-approved medicines and numerous product candidates in a range of diseases, including blindness-causing eye diseases, severe inflammatory conditions like asthma and atopic dermatitis, hematologic conditions, pain and infectious diseases such as Ebola and COVID-19.

Analyst Center

Interactive

Analyst Center

Interactive and downloadable financial data for investors and analysts

Contact us

Investor Relations

914.847.7741

Media Relations